Day: June 2, 2020

Paris, 2nd June 2020, 17:45COFACE SA: Disclosure of total number of voting rights and number of shares in the capital as at 31 May 2020Attachment2020 05 31 Declaration Shares&Voting Rights EN

Paris, le 2 juin 2020 – 17h45                                                    COFACE SA : Déclaration du nombre total des droits de vote et du nombre d’actions composant le capital social au 31 mai 2020y compris actions auto-détenuesdéduction faite des actions auto-détenuesPièce jointe2020 05 31 Declaration Actions&Droits de Vote FR

Nicox SASociété anonyme with a registered capital of € 33,491,370Head Office:DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642On June 2, 2020,MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS(Article L.233-8 II of the Code de Commerce and Articles 221-1 and 223-16 of the Règlement général of the l’AMF)—————www.nicox.comPhone: +33 4-97-24-53-00Fax : +33  4-97-24-53-99Attachment31 mai 2020 EN

Nicox SASociété anonyme au capital de 33 491 370 eurosSiège social :DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642Le 2 juin 2020,PUBLICATION MENSUELLE DU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL ET DU NOMBRE TOTAL DE DROITS DE VOTE(Article L.233-8 II du Code de Commerce et les Articles 221-1 et 223-16 du Règlement général de l’AMF)—————www.nicox.comTel :   04-97-24-53-00Fax :  04-97-24-53-99Pièce jointe31 mai 2020 FF

Daix (France), June 2, 2020 – Inventiva (Euronext: IVA), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced that Frédéric Cren, Chairman, CEO and cofounder of Inventiva, will participate in a fireside chat and engage in one-on-one investor meetings at the upcoming Jefferies Virtual Healthcare Conference, being held virtually on June 2-4, 2020.The event details of the fireside chat are as follows:Date: Thursday, June 4, 2020Time: 8:00 am – 8:25 am (Eastern Time)Format: Video presentationLive and replay link: http://wsw.com/webcast/jeff126/iva/The presentation document and the above link will also be available on Inventiva’s website in the “Investors”...

Daix (France), le 2 juin 2020 – Inventiva (Euronext : IVA), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par voie orale pour le traitement de la stéatohépatite non alcoolique (NASH), des mucopolysaccharidoses (MPS) et d’autres maladies avec un besoin médical non satisfait significatif, annonce aujourd’hui que Frédéric Cren, Président-directeur général et cofondateur d’Inventiva, présentera la Société et ses activités et participera à des rendez-vous investisseurs lors de la « Jefferies Virtual Healthcare Conference » qui se tiendra virtuellement du 2 au 4 juin 2020.Les détails de la présentation sont les suivants :Date : Jeudi 4 juin 2020Heure : 08h00 – 08h25 (heure de la côte Est)Format : Présentation vidéo  Lien : http://wsw.com/webcast/jeff126/iva/Le document de présentation...

Rovio Entertainment Corporation – Repurchase of own shares on 2 June 2020Rovio Entertainment Corporation                 STOCK EXCHANGE RELEASE                   2 June 2020 AT 18:45 EETIn the Nasdaq HelsinkiDate                                                                                2 June 2020Exchange transaction                                                       BuyShare trading code                                                           ROVIOAmount, shares                                                                49247Average price/share, EUR                                                 5,510189Total cost, EUR                                                                271360,28ROVIO now holds a total of 6 264 885 own shares (ROVIO) including the shares repurchased on 2 June 2020.On behalf of Rovio Entertainment...

MONTREAL, June 02, 2020 (GLOBE NEWSWIRE) — AM Resources Corporation (“the Company”) (TSX VENTURE: AMR) announces that due to Covid-19 circumstances it will delay its interim consolidated financial statements and its management discussion and analysis until on or about July 16, 2020. The Company is relying upon temporary relief granted by the Autorité des marches financiers (AMF) allowing reporting issuers to extend certain continuous disclosure filing deadlines occurring during the period from March 23, 2020 to June 1, 2020 by 45 days.Management and directors of the Company are subject to an insider trading black-out policy until the delayed filings are completed, reflecting the principles in section 9 of National Policy 11-207 Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions.The Company confirms...